Uridine triphosphate (UTP) can be released from damaged cells to cause vasoconstriction. Although UTP is known to act through P2Y receptors and PLC activation in vascular smooth muscle, the role of PKC in generating the response is somewhat unclear. Here we have used Tat-linked membrane permeable peptide inhibitors of PKC to assess the general role of PKC and also of specific isoforms of PKC in the UTP induced contraction of rat mesenteric artery. We examined the effect of PKC inhibition on UTP induced contraction, increased cytoplasmic Ca 2+ and reduction of K + currents and found that PKC inhibition caused a relatively small attenuation of contraction but had little effect on changes in cytoplasmic Ca
Introduction
Contraction of arterial smooth muscle results from an increase in internal [Ca 2+ ], occurring either by entry through Ca 2+ permeable channels or by release from intracellular Ca 2+ stores. Many vasoconstrictors stimulate G q linked receptors activating phospholipase C leading to generation of DAG, IP 3 and subsequent activation of PKC and Ca 2+ release. In many instances intracellular Ca 2+ is raised further through PKC induced reduction of K + currents causing depolarization and subsequent activation of L-type Ca 2+ channels (1) . For example, we and others have shown that PKC is involved in generating the contraction of arterial smooth muscle in response to both Ang II and ET-1 (2) (3) (4) . UTP, which is released in response to cellular injury (5) , causes contraction of vascular smooth muscle by activating G-protein coupled P2Y receptors (6, 7) ; but in rat cerebral arteries UTP induced contraction was unaffected by the general PKC inhibitor bisindolylmaleimide and UTP inhibition of voltage-gated K + channels was not dependent on PKC (8) . However, in rat mesenteric artery smooth muscle cells UTP, Ang II and ET-1 all increase intracellular Ca 2+ and induce the translocation of PKCα, PKCδ and PKCε (9) . Interestingly, the contraction induced by Ang II works almost exclusively through PKCε while ET-1 works through PKCα (4), but whether specific PKC isoforms are involved in generating UTP induced contraction is not known.
In this study we have used myography, Ca 2+ imaging and electrophysiological techniques to investigate the degree of PKC involvement in the signalling mechanisms of UTP induced contraction of rat mesenteric
arteries. In our study we have used cell-permeable general and isoform specific peptide inhibitors of PKC and found that PKC activation has only a minimal role in generating UTP induced contraction. Our data also show that UTP induced attenuation of K + currents is dependent on intracellular Ca
2+
.
Materials and Methods

Preparation of arterial smooth muscle cells
All experiments were carried out on adult male Wistar rats (200-300 g) killed by stunning and cervical dislocation. The care of animals was in accordance with the UK Animals (scientific procedures) Act 1986.
Investigations carried out in this study conformed to the Guide for the Care and use of laboratory animals published by the US National Institutes of Health (NIH publications No. 85-23 revised 1996). The procedures used in this study were approved by the University of Leicester Animal Care and Use Committee.
The mesentery was cleaned of fat and connective tissue and mesenteric arteries were either stored in ice cold physiological saline for myography or were immediately subjected to enzymatic digestion to obtain isolated smooth muscle cells as described previously by Rainbow et al. (10) . Briefly, the arteries were incu- 
Solutions and chemicals
For myography experiments the physiological bathing solution comprised (mM): 135 NaCl, 
Myography
To record contractile force, 2-4 mm segments of third order mesenteric arteries were mounted in a Myointerface model 500A myograph (JP Trading, Denmark). In addition to the compounds being tested, all bathing solutions contained 20 µM L-NAME to eliminate endogenous nitric oxide synthesis and were added to the bath directly, which was maintained at 37°C.
Ca
2+ imaging
Intracellular Ca 2+ was measured in isolated mesenteric arterial smooth muscle cells cultured for 3 days.
Cells were pre-loaded with Fura-2-AM (5 μM) for 30 minutes. Fluorescent signals were measured every 3
seconds following alternate excitation with 340 and 380 nm light using a monochromator (deltaRAM, Photon
Technology, UK) and 45 second pulses of UTP were applied every 3 minutes to stimulate Ca 2+ release. Emitted light >520 nm was recorded with a Roper Scientific CCD97 camera and values are expressed as the ratio of light emitted following excitations at 340 and 380 nm respectively. All measurements were made at 30-32 °C.
Electrophysiology
Whole-cell K v and K ATP currents were recorded from single smooth muscle cells using the patch clamp technique. Currents were filtered at 2 kHz (-3 dB) and recorded with an Axopatch 200A amplifier (Molecular Devices) and digitized at 10 kHz. Patch pipettes were made from thick-walled borosilicate glass (Clark Electromedical, Pangbourne, Berks, UK) using a pp-83 vertical puller (Narishige, Tokyo, Japan). Electrode resistances before sealing were 3-5 MΩ and after sealing were >1 GΩ . All experiments were done at 30°C, maintained using a Dagan HW-30 temperature controller.
Analysis
Results are expressed as means ± S.E.M. Intergroup differences were tested by analysis of variance followed by Bonferroni's post hoc test, P<0.05 was considered statistically significant.
Results
UTP induced contraction depends on Ca 2+ entry
Under control conditions (6 mM K + and 1.8 mM Ca
2+
) we found that repeated 5 minute applications of UTP (100 µM) with 10 minute wash intervals gave consistent contractions for at least 8 applications. This enabled comparisons of the contractions before and after pharmacological interventions without desensitization of UTP responses being a major factor; thus for all myography experiments described we used 100 µM UTP. Fig. 1A shows contractile responses to 60 mM K + and to UTP in the absence and presence of diltiazem (50 µM), an L-type Ca 2+ channel blocker. As expected, the response to 60 mM K + was completely abolished by diltiazem, indicating that the depolarization induced by 60 mM K + activated L-type channels causing Ca 
UTP induces Ca 2+ release
Since blocking Ca 2+ entry through L-type Ca 2+ channels only partially reduced UTP induced contraction we examined changes in Ca 2+ induced fluorescence of Fura-2 by UTP in the presence of 0.1 and 1.3 mM . As can be seen in Fig. 2A 
PKC inhibitor peptides are relatively ineffective at inhibiting UTP induced responses
We have shown that the vasoconstrictors AngII, ET-1 and UTP all mobilize PKCα, PKCδ and PKCε in mesenteric smooth muscle cells (9) . We investigated the extent of various PKC isoform involvement in UTP (Fig. 3B) . It is evident that Tat-PKCα-IP inhibited the ET-1 induced contraction significantly and to a similar extent as in our previous work (4) . UTP responses could be compared directly (normalized to control UTP induced contractions) and as Fig. 3C shows, in contrast to ET-1, UTP induced contractions were unaffected by Tat-PKCα-IP. None of the PKC isoform-specific peptide blockers affected UTP induced contractions, only the non-specific peptide blocker Tat-PKC 20-28 -IP produced a small but significant inhibition of UTP induced contractions (decreased to 82.8 ± 6.8%, P<0.05, n=7). We found that the UTP induced increase in Fura-2 ratio (with 1.3 mM Ca
2+
) was also reduced slightly, but not significantly, by pre-treatment with Tat-PKC 20-28 -IP (Fig. 2D) . 
UTP reduces Kv current in a Ca 2+ -dependent manner
Whole-cell K v currents were induced following depolarizing voltage pulses to potentials more positive than about -40 mV from a holding potential of -65 mV. To minimize contamination by BK channel activity, penitrem A (100 nM), a specific BK channel blocker, was included in the external solution (11) . K v current density (normalized to cell capacitance) was quite variable in these cells; for this reason we have plotted currents normalized to control current at +60 mV to enable comparison between cells. The average cell capacitance of mesenteric arterial smooth muscle cells was 13.9 ± 0.7 pF and the average current recorded was 290 ± 52 pA at +60 mV. Kv current densities measured at +60 mV under control conditions (100 nM penitrem A) were 18.7 ± 2.7 (n=9) and 21. , UTP did not inhibit K v currents (see Fig. 4A & B).
PKC inhibition reduces but does not abolish UTP modulation of K v currents
To assess the involvement of PKC in the UTP induced modulation of K v currents a comparison of the inhibition was made in the absence and presence of Tat-PKC 20-28 -IP, a non-isoform specific inhibitor of PKC.
As shown in 
K ATP channels are strongly inhibited by UTP in a Ca 2+ dependent manner
To measure K ATP currents the membrane potential was held at -60 mV and external K + was raised from 6 to 140 mM, setting E K at 0 mV and resulting in inward K ATP currents. At this membrane potential K v and BK currents were virtually absent. Pinacidil (10 µM) was used to activate K ATP channels further and their identity was confirmed by applying the K ATP channel blocker glibenclamide (10 µM). Application of UTP (100 µM) following activation by pinacidil caused a marked reduction in K ATP current when the pipette solution contained 100 nM free Ca
2+
, but, similar to the case with K v currents, UTP inhibition was much less and did not reach statistical significance when the pipette contained only 20 nM free Ca 2+ (Fig. 5) .
PKC inhibition has little effect on UTP modulation of K ATP currents
To establish the extent of PKC involvement in the UTP induced inhibition of K ATP currents cells were pre-exposed to 100 nM Tat-PKC 20-28 -IP for at least 10 minutes before recording. Whole-cell recordings were established with 100 nM Ca 2+ in the pipette and a comparison of the UTP inhibition of pinacidil activated K ATP currents between control cells and pre-treated cells was made. No significant difference between the inhibition of K ATP current by UTP in control cells and in cells pre-treated with Tat-PKC 20-28 -IP (n=8) was observed (Fig.   5C ).
Discussion
In the presence of a functional epithelium, endothelial P2Y1 receptor activation results in mesenteric arteriole dilation (12, 13) . However, if the endothelial layer is damaged or, as in our experiments, nitric oxide synthesis is supressed, UTP causes a potent contraction of rat mesenteric artery segments. This is partly . (D) Mean I-V plots, normalized to control current at +60 mV, under the conditions of part C (n=9). (E) Examples of whole-cell currents under control conditions and 9 minutes after applying UTP (100 μM). These currents were recorded from a cell pre-treated for over 10 minutes with Tat-PKC 20-28 -IP (100 nM) and with 100 nM free Ca 2+ in the patch pipette. (F) Mean I-V plots, normalized to control current at +60 mV, under the conditions of part E (n=7).
dependent on Ca 2+ entry through L-type Ca 2+ channels, as indicated by the ability of diltiazem to reduce the contraction to about 50% of control values (see Fig. 1C ). UTP induced contraction of rat cerebral arteries was also sensitive to diltiazem but to a somewhat lesser degree (8) . UTP is known to activate G q linked P2Y1, P2Y2, P2Y4 and P2Y6 receptors on vascular smooth muscle which generate PLC dependent Ca 2+ signals (6, 7, 14 muscle with contributions from both P2X and P2Y receptor signalling. These authors show that Ca 2+ entry through L-type channels mediate a phasic contraction while Ca 2+ release from endoplasmic reticulum caused tonic contraction of rat aortic rings (16) .
We have shown previously that UTP causes mobilization of PKCα, δ and ε in these cells (9) . However, examination of the PKC dependence revealed that both contraction and the increased Ca 2+ in response to UTP were relatively insensitive to Tat-linked membrane permeable peptide inhibitors of PKC (see Fig. 2D & 3C) .
The general PKC inhibitor peptide, Tat-PKC 20-28 -IP, was the only one to cause a small but significant decrease (17%) in the contraction; isoform specific inhibitors were without effect, although the ET-1 contraction was strongly inhibited by Tat-PKCα-IP as we have reported previously (4).
Many vasoconstrictors reduce smooth muscle K + currents causing depolarization and activation of L-type Ca 2+ channels which increases contraction. UTP has been shown to inhibit K v channels of rat cerebral arteries (8) and K ATP channels in rat coronary arteries (17) . We also found that UTP reduced K v currents and K ATP currents of rat mesenteric arteries when the pipette contained 100 nM free Ca 2+ ( Fig. 4C & D) . Of note, however, was that lowering pipette [Ca 2+ ] from 100 to 20 nM abolished UTP inhibition of both currents ( Fig. 4A & B) . This is unlikely to result from BK channel inhibition at the higher Ca 2+ level as these experiments were done in the presence of the BK channel blocker penitrem A. Furthermore, no difference in current density between cells recorded with 20 or 100 nM Ca 2+ in the pipette was observed, indicating that BK current was absent under our recording conditions. In rat cerebral artery UTP still reduced K v currents in the presence of the PKC inhibitor bisindolylmaleimide, but the reduction was not to the same degree as in its absence (8); we found a similar effect with the more specific peptide PKC inhibitor Tat-PKC 20-28 -IP on UTP reduction of mesenteric artery smooth muscle K v currents (Fig. 4E & F) . The inhibition of mesenteric artery K ATP currents by UTP was considerable, with 100 μM UTP leading to an 85% reduction in K ATP current; as was the case with K v currents, lowering pipette free [Ca 2+ ] to 20 nM virtually abolished the effect of UTP. The inhibition of K ATP currents by UTP persisted in cells pre-treated with Tat-PKC 20-28 -IP (Fig. 5) . It is known that activation of PLC is enhanced by Ca 2+ (18) , and recently Jones et al. (19) have shown that Ca 2+ entry through P2X receptors can enhance ADP responses acting through P2Y receptors in platelets, possibly by a mechanism that involves enhanced PLC activation. Although the mechanism whereby intracellular Ca 2+ appears necessary for UTP signalling to K + channels in our experiments is unclear, a reduced PLC activation in experiments with low (20 nM) intracellular Ca 2+ is certainly plausible.
We have shown that DiC8, an analogue of DAG, is an effective blocker of K v and to a lesser extent K ATP currents in these cells (11) . This raises the possibility that DAG produced following PLC activation may contribute to the UTP induced reduction of both K V and K ATP currents; it should be noted, however, that another DAG analogue (OAG), did not inhibit K V currents (11). Furthermore, Luykenaar et al. (8) have shown that in rat cerebral artery smooth muscle cells the Rho kinase inhibitor Y27632 abolished the inhibition of K V currents by UTP.
In conclusion, the contraction of rat mesenteric arteries by UTP is rather insensitive to peptide inhibitors of various PKC isoforms. The contraction depends partly on Ca 2+ entry through L-type Ca 2+ channels, but Ca 2+ release is also important. In addition to initiating contraction, it appears that intracellular Ca 2+ is also necessary for UTP signalling, as the reduction in both K v and K ATP currents are virtually abolished if free [Ca 2+ ] is lowered to 20 nM. This raises the interesting possibility that UTP induced vasospasm has a positive feedback component, where raised intracellular Ca 2+ increase the ability of UTP to inhibit K + currents, thereby leading to increased depolarization and further Ca 2+ entry.
